Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03146676 · ClinicalTrials.gov registry record
The Ohio State University Dermatology Biorepository
A clinical trial of Hidradenitis Suppurativa, sponsored by Ohio State University.
- Recruiting
- Registry status
- 175
- Enrollment target
- 1
- Study location
NCT03146676 is a study of Hidradenitis Suppurativa that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 175 participants, below the 595-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03146676, a study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Conditions Studied
Study Locations (1)
Ohio
- OSU Dermatology West - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2017-04-19 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03146676
The ClinicalTrials.gov registry entry for NCT03146676 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 595-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (71% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 0 interventions.
NCT03146676 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03146676 about?
NCT03146676 is a clinical study titled "The Ohio State University Dermatology Biorepository". This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
What is the current status of trial NCT03146676?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2017-04-19. Estimated completion is 2030-12-31.
What conditions does trial NCT03146676 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa.
Who is sponsoring clinical trial NCT03146676?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03146676 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hidradenitis Suppurativa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aviclear for Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
RECRUITING · Phase 2
-
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RECRUITING · Phase 1
-
An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)
RECRUITING · Phase 3
-
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
RECRUITING · Phase 3
-
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.